000 01501 a2200397 4500
005 20250516172106.0
264 0 _c20140303
008 201403s 0 0 eng d
022 _a1551-0018
024 7 _a10.3934/mbe.2013.10.803
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLedzewicz, Urszula
245 0 0 _aOn the MTD paradigm and optimal control for multi-drug cancer chemotherapy.
_h[electronic resource]
260 _bMathematical biosciences and engineering : MBE
_cJun 2013
300 _a803-19 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDrug Administration Schedule
650 0 4 _aHumans
650 0 4 _aLinear Models
650 0 4 _aMathematical Concepts
650 0 4 _aMaximum Tolerated Dose
650 0 4 _aModels, Biological
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPopulation Dynamics
650 0 4 _aSystems Biology
700 1 _aSchättler, Heinz
700 1 _aGahrooi, Mostafa Reisi
700 1 _aDehkordi, Siamak Mahmoudian
773 0 _tMathematical biosciences and engineering : MBE
_gvol. 10
_gno. 3
_gp. 803-19
856 4 0 _uhttps://doi.org/10.3934/mbe.2013.10.803
_zAvailable from publisher's website
999 _c23114230
_d23114230